TY - JOUR
T1 - Microbiota modulation of myeloid cells in cancer therapy
AU - Goldszmid, Romina S.
AU - Dzutsev, Amiran
AU - Viaud, Sophie
AU - Zitvogel, Laurence
AU - Restifo, Nicholas P.
AU - Trinchieri, Giorgio
N1 - Publisher Copyright:
© 2015 American Association for Cancer Research.
PY - 2015/2/1
Y1 - 2015/2/1
N2 - Myeloid cells represent a major component of the tumor microenvironment, where they play divergent dual roles. They can induce antitumor immune responses, but mostly they promote immune evasion, tumor progression, and metastasis formation. Thus, strategies aiming at reprogramming the tumor microenvironment represent a promising immunotherapy approach. Myeloid cells respond to environmental factors including signals derived from commensal microbes. In this Cancer Immunology at the Crossroads overview, we discuss recent advances on the effects of the commensal microbiota on myeloid-cell functions and how they affect the response to cancer therapy.
AB - Myeloid cells represent a major component of the tumor microenvironment, where they play divergent dual roles. They can induce antitumor immune responses, but mostly they promote immune evasion, tumor progression, and metastasis formation. Thus, strategies aiming at reprogramming the tumor microenvironment represent a promising immunotherapy approach. Myeloid cells respond to environmental factors including signals derived from commensal microbes. In this Cancer Immunology at the Crossroads overview, we discuss recent advances on the effects of the commensal microbiota on myeloid-cell functions and how they affect the response to cancer therapy.
UR - http://www.scopus.com/inward/record.url?scp=84962223346&partnerID=8YFLogxK
U2 - 10.1158/2326-6066.CIR-14-0225
DO - 10.1158/2326-6066.CIR-14-0225
M3 - Article
C2 - 25660553
AN - SCOPUS:84962223346
SN - 2326-6066
VL - 3
SP - 103
EP - 109
JO - Cancer Immunology Research
JF - Cancer Immunology Research
IS - 2
ER -